| Heidi Ann Bergen, APRN, NP-C | |
|
315 N C St, Edgar, NE 68935-3194 | |
| (402) 224-3344 | |
| (402) 224-3099 |
| Full Name | Heidi Ann Bergen |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 13 Years |
| Location | 315 N C St, Edgar, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184919615 | NPI | - | NPPES |
| 111253 | Other | NE | STATE OF NEBRASKA-APRN |
| 55203 | Other | NE | STATE OF NEBRASKA-RN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 111253 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brodstone Memorial Hosp | Superior, NE | Hospital |
| Mary Lanning Healthcare | Hastings, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brodstone Memorial Hospital | 4082513015 | 10 |
News Archive
Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Lm) biotechnology company, enrolled and has administered its initial dose to its third patient in its US Food and Drug Administration (FDA)-approved, phase II clinical trial in cervical intraepithelial neoplasia (CIN), commonly known as cervical dysplasia.
TomoTherapy Incorporated announced today that there will be more than 40 presentations at the 10th Biennial ESTRO Conference on Physics and Radiation Technology for Clinical Radiotherapy that explore use of the TomoTherapy treatment system. The TomoTherapy system - a versatile, CT scanner-based device that integrates image guidance for increased treatment accuracy and helical radiation therapy delivery for enhanced tumor targeting - is helping cancer centers advance patient care around the world.
A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against multiple flu virus strains has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland.
The Spectranetics Corporation today announced FDA approval of the new advanced GlideLight Laser Sheath for removal of cardiac leads. As part of the company's vision to safely manage every lead, GlideLight delivers more precise control to reduce the force for safe lead extraction.
Audits of a state prison and psychiatric hospital detail hundreds of thousands of dollars in improper payments and financial problems, including outright payroll fraud, and medical staff and guards receiving questionable bonuses and holiday pay, according to reports released Wednesday (St. John, 8/20).
› Verified 5 days ago
| Entity Name | Brodstone Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073590626 PECOS PAC ID: 4082513015 Enrollment ID: O20040423000949 |
News Archive
Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Lm) biotechnology company, enrolled and has administered its initial dose to its third patient in its US Food and Drug Administration (FDA)-approved, phase II clinical trial in cervical intraepithelial neoplasia (CIN), commonly known as cervical dysplasia.
TomoTherapy Incorporated announced today that there will be more than 40 presentations at the 10th Biennial ESTRO Conference on Physics and Radiation Technology for Clinical Radiotherapy that explore use of the TomoTherapy treatment system. The TomoTherapy system - a versatile, CT scanner-based device that integrates image guidance for increased treatment accuracy and helical radiation therapy delivery for enhanced tumor targeting - is helping cancer centers advance patient care around the world.
A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against multiple flu virus strains has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland.
The Spectranetics Corporation today announced FDA approval of the new advanced GlideLight Laser Sheath for removal of cardiac leads. As part of the company's vision to safely manage every lead, GlideLight delivers more precise control to reduce the force for safe lead extraction.
Audits of a state prison and psychiatric hospital detail hundreds of thousands of dollars in improper payments and financial problems, including outright payroll fraud, and medical staff and guards receiving questionable bonuses and holiday pay, according to reports released Wednesday (St. John, 8/20).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heidi Ann Bergen, APRN, NP-C Po Box 406, Edgar, NE 68935-0406 Ph: (402) 224-3344 | Heidi Ann Bergen, APRN, NP-C 315 N C St, Edgar, NE 68935-3194 Ph: (402) 224-3344 |
News Archive
Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Lm) biotechnology company, enrolled and has administered its initial dose to its third patient in its US Food and Drug Administration (FDA)-approved, phase II clinical trial in cervical intraepithelial neoplasia (CIN), commonly known as cervical dysplasia.
TomoTherapy Incorporated announced today that there will be more than 40 presentations at the 10th Biennial ESTRO Conference on Physics and Radiation Technology for Clinical Radiotherapy that explore use of the TomoTherapy treatment system. The TomoTherapy system - a versatile, CT scanner-based device that integrates image guidance for increased treatment accuracy and helical radiation therapy delivery for enhanced tumor targeting - is helping cancer centers advance patient care around the world.
A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against multiple flu virus strains has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland.
The Spectranetics Corporation today announced FDA approval of the new advanced GlideLight Laser Sheath for removal of cardiac leads. As part of the company's vision to safely manage every lead, GlideLight delivers more precise control to reduce the force for safe lead extraction.
Audits of a state prison and psychiatric hospital detail hundreds of thousands of dollars in improper payments and financial problems, including outright payroll fraud, and medical staff and guards receiving questionable bonuses and holiday pay, according to reports released Wednesday (St. John, 8/20).
› Verified 5 days ago